Physician profile
Johnny Le
NPI 1982271862
$420.81
in general payments reported to CMS, 2019-2025
16 companies · $24.28 in 2025
The $24.28 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $16.84 · 2022: $231 · 2023: $149 · 2025: $24.28.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $173.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $172.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $77.20 | 2022 | |
| Lilly USA, LLC | $34.30 | 2022-2023 | Mounjaro |
| Novo Nordisk INC | $33.60 | 2022 | |
| Idorsia Pharmaceuticals US INC | $29.94 | 2023 | Quviviq |
| Novartis Pharmaceuticals Corporation | $29.00 | 2022-2023 | |
| Astellas Pharma US INC | $27.54 | 2022-2023 | Myrbetriq |
| Boston Scientific Corporation | $24.28 | 2025 | Wavewriter Alpha Prime 16 |
| Glaxosmithkline, LLC. | $23.40 | 2023 | Trelegy Ellipta |
| Pfizer INC. | $22.79 | 2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $22.53 | 2022 | |
| Alkermes, INC. | $20.59 | 2022 | |
| Baxter Healthcare | $20.06 | 2023 | Hillrom - Volara System |
| Indivior INC. | $16.84 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $14.63 | 2022 | |
| Axsome Therapeutics, INC. | $12.41 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $11.70 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Johnny Le listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.